Vertex Pharmaceuticals Inc / Ma

FOSTER DYKEMA CABOT & PARTNERS, LLC VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

58,344

Value ($000)

26,451

Weight

1.6%

2025 Q2 - 2025 Q4 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	26,451	1.6%	58,344	12/31/2025
2025 Q3	11/12/2025	23,770	1.6%	60,689	9/30/2025
2025 Q2	8/12/2025	27,121	1.9%	60,923	6/30/2025